Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Hee Kee Kim"'
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Ketamine, an N-methyl-D-aspartate receptor antagonist, is widely known as a dissociative anesthetic and phencyclidine derivative. Due to an undesirable adverse event profile when used as an anesthetic it had widely fallen out of human use in favor of
Externí odkaz:
https://doaj.org/article/a398902e3fa749dabe36bcc88a351f5e
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
Chemotherapy-induced neuropathic pain is a significant side effect of chemotherapeutic agents and is the most common reason for stopping chemotherapy. The aim of the present study was to find the major site and mechanisms of action by which rolipram,
Externí odkaz:
https://doaj.org/article/59cdfc34f66d4465b1a9a712b257b781
Publikováno v:
Neural Plasticity, Vol 2015 (2015)
Our previous studies suggest that reactive oxygen species (ROS) scavengers have analgesic effect on neuropathic pain through spinal mechanisms in the rat. The studies suggest that superoxide in spinal cord is one of important mediators of persistent
Externí odkaz:
https://doaj.org/article/a36b4ab0dad94beb94adf07c70cba182
Publikováno v:
International journal of molecular sciences. 23(18)
Pain plays an important role in human survival [...]
Autor:
Min-Sik Kim, Jingi Bae, Sang Won Lee, Hee Kee Kim, Youn Sang Jung, Seung Eun Lee, Patrick M. Dougherty, Salahadin Abdi, Seon Hee Hwang, Seunghoon Back, Jae Il Park, Hangyeore Lee, Moon Jong Kim, Sohee Jun, Sung Ho Lee, Christopher L. Cervantes
Publikováno v:
Neurotherapeutics
Although chemotherapy is a key cancer treatment, many chemotherapeutic drugs produce chronic neuropathic pain, called chemotherapy-induced neuropathic pain (CINP), which is a dose-limiting adverse effect. To date, there is no medicine that prevents C
Autor:
Kazuhiro Yagita, Mark J. Burish, Jin Mo Chung, Nobuya Koike, Marvin Wirianto, Hee Kee Kim, Sun Yeul Lee, Zheng Chen, Salahadin Abdi, Hyun Kyoung Lee, Eunju Kim, Seung Hee Yoo
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific Reports
Scientific Reports
Growing evidence demonstrates circadian rhythms of pain hypersensitivity in various chronic disorders. In chemotherapy-induced peripheral neuropathy (CIPN), agents such as paclitaxel are known to elicit chronic neuropathic pain in cancer patients and
Publikováno v:
Current opinion in anaesthesiology. 33(6)
Purpose of review The prevalence of cancer pain will continue to rise as pain is common among the survivorship and general cancer population. As interest in cannabis and cannabinoids for medicinal use including pain management continues to rise, ther
Publikováno v:
Molecular neurobiology. 56(11)
Chemotherapy-induced peripheral neuropathy (CIPN) adversely impacts quality of life and a challenge to treat with existing drugs used for neuropathic pain. Losartan, an angiotensin II type 1 receptor (AT1R) antagonist widely used to treat hypertensio
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 8 (2017)
Frontiers in Pharmacology, Vol 8 (2017)
Chemotherapy-induced neuropathic pain is a significant side effect of chemotherapeutic agents and is the most common reason for stopping chemotherapy. The aim of the present study was to find the major site and mechanisms of action by which rolipram,
Publikováno v:
Frontiers in Pharmacology
Chemotherapy-induced neuropathic pain is difficult to treat and prevent. Tempol decreases cellular superoxide radical levels and oxidative stress. The aims of our study were to investigate the analgesic and preventive effects of tempol on paclitaxel-